We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.31B
1-Year Est. Return 18.36%
This Fund
S&P 500
This Quarter Est. Return
+1.65%
1 Year Est. Return
+18.36%
3 Year Est. Return
+53.76%
5 Year Est. Return
+60.8%
10 Year Est. Return
+204.74%
AUM
$2.25B
AUM Growth
+$68.7M
Cap. Flow
+$47.8M
Cap. Flow %
2.12%
Top 10 Hldgs %
19.72%
Holding
2,202
New
81
Increased
603
Reduced
556
Closed
149

Sector Composition

Rank Sector Weight
1 Technology 8.69%
2 Financials 4.6%
3 Healthcare 4.02%
4 Consumer Discretionary 3.1%
5 Industrials 2.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMHY icon
1076
iShares JPMorgan EM High Yield Bond ETF
EMHY
$627M
$48.8K ﹤0.01%
1,318
+192
+17% +$7.14K
CHI
1077
Calamos Convertible Opportunities and Income Fund
CHI
$1.04B
$48.8K ﹤0.01%
4,190
-190
-4% -$2.14K
QCLN icon
1078
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$616M
$48.8K ﹤0.01%
1,434
VTR icon
1079
Ventas
VTR
$47.5B
$48.6K ﹤0.01%
949
LNG icon
1080
Cheniere Energy
LNG
$53.4B
$48.5K ﹤0.01%
277
-38
-12% -$6.05K
MLCO icon
1081
Melco Resorts & Entertainment
MLCO
$2.19B
$48.4K ﹤0.01%
6,493
SPH icon
1082
Suburban Propane Partners
SPH
$1.18B
$48.4K ﹤0.01%
2,550
MCO icon
1083
Moody's
MCO
$83.8B
$48.4K ﹤0.01%
115
+11
+11% +$4.38K
IBDQ
1084
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
$48.2K ﹤0.01%
1,938
XSD icon
1085
State Street SPDR S&P Semiconductor ETF
XSD
$2.84B
$48K ﹤0.01%
194
MTZ icon
1086
MasTec
MTZ
$21.4B
$47.9K ﹤0.01%
448
+13
+3% +$1.31K
SGDJ icon
1087
Sprott Junior Gold Miners ETF
SGDJ
$308M
$47.8K ﹤0.01%
1,550
AGNT
1088
AGNT Inc
AGNT
$666M
$47.6K ﹤0.01%
4,220
CRSP icon
1089
CRISPR Therapeutics
CRSP
$5.17B
$47.5K ﹤0.01%
880
+9
+1% +$521
FFIN icon
1090
First Financial Bankshares
FFIN
$5.06B
$47.2K ﹤0.01%
1,600
LVS icon
1091
Las Vegas Sands
LVS
$29.7B
$47.1K ﹤0.01%
1,065
+51
+5% +$2.38K
EFX icon
1092
Equifax
EFX
$20.8B
$47K ﹤0.01%
194
+114
+143% +$27.2K
MPWR icon
1093
Monolithic Power Systems
MPWR
$66.1B
$46.8K ﹤0.01%
57
IGLD icon
1094
FT Vest Gold Strategy Target Income ETF
IGLD
$524M
$46.8K ﹤0.01%
2,337
NWN icon
1095
Northwest Natural Holdings
NWN
$2.08B
$46.7K ﹤0.01%
1,292
XAR icon
1096
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.38B
$46.5K ﹤0.01%
332
KAPR icon
1097
Innovator US Small Cap Power Buffer ETF April
KAPR
$218M
$46.2K ﹤0.01%
+1,500
New +$45.8K
PYN
1098
DELISTED
PIMCO New York Municipal Income Fund III
PYN
$45.9K ﹤0.01%
7,779
+3,300
+74% +$19.2K
DFCF icon
1099
Dimensional Core Fixed Income ETF
DFCF
$10.9B
$45.8K ﹤0.01%
1,103
+384
+53% +$15.9K
DEED icon
1100
First Trust Securitized Plus ETF
DEED
$64.4M
$45.5K ﹤0.01%
2,204
+347
+19% +$7.11K

Similar funds

Geneos Wealth Management's Q2 2024 Portfolio in Review

As of Q2 2024, Geneos Wealth Management held 2,202 positions worth $2.25B, up 3.1% from $2.18B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Geneos Wealth Management's Q2 2024 filing shows 81 new, 603 increased, 556 reduced and 149 closed positions. Its largest new stake was Dimensional International Core Equity 2 ETF: 225,058 shares worth $5.92M. The largest sale was iShares Core S&P Small-Cap ETF, an estimated $16M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8% a quarter earlier, followed by Financials and Healthcare.

  • Geneos Wealth Management's largest Q2 2024 buy was Dimensional International Core Equity 2 ETF: 225,058 shares worth $5.92M.
  • Geneos Wealth Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $28.5M increase.
  • Geneos Wealth Management's biggest Q2 2024 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $16M.
  • Geneos Wealth Management fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $2.03M.
  • Geneos Wealth Management's ten largest holdings make up 20% of its $2.25B portfolio in Q2 2024.
  • Geneos Wealth Management opened 81 new positions and closed 149 in Q2 2024.
  • Geneos Wealth Management's portfolio value rose 3.1% quarter-over-quarter to $2.25B.

Based on Geneos Wealth Management's 13F filing for Q2 2024, filed 23 Jul 2024.